2 Apr 2012 15:06
For immediate release | 2 April 2012 |
Futura Medical plc
("Futura" or "the Company")
Notice of AGM
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that its AGM notice (including Explanatory Notes and Form of Proxy) has been posted to shareholders. The AGM will be held at 10am on 9 May 2012.
Futura's annual report and accounts for the year ended 31 December 2011 is available at the Company's website www.futuramedical.com.
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive
| Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
Nomura Code Securities Limited |
|
Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
|
|
For media enquiries please contact: |
|
|
|
Buchanan |
|
Mark Court / Jessica Fontaine | Tel: +44 (0)20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
Futura Medical (FUM)